Benzinga | Oct 21, 2021 12:11PM EDT

HC Wainwright & Co. Maintains Neutral on Radius Health, Raises Price Target to $26

HC Wainwright & Co. analyst Douglas Tsao maintains Radius Health (NASDAQ:RDUS) with a Neutral and raises the price target from $19 to $26.